Celltrion | 068270 - Operating Profit

Stock Price
204,000.00
Daily Change
-5,000.00 -2.39%
Monthly
1.24%
Yearly
29.11%
Q2 Forecast
197,024.30

Celltrion reported KRW301.04B in Operating Profit for its fiscal quarter ending in September of 2025.





Operating Profit Change Date
Akebia Therapeutics USD -5.45M 9.4M Dec/2025
Alaunos Therapeutics USD -1.19M 148K Sep/2025
Avita Medical AUD -10.41M 742K Dec/2025
Celltrion KRW 301.04B 58.57B Sep/2025
Dianthus Therapeutics USD -69.54M 29.25M Dec/2025
Ionis Pharmaceuticals USD -215M 54.82M Dec/2025
IQVIA Holdings USD 2.68B 2.1B Dec/2025
Moderna USD -857M 597M Dec/2025
Organon & Co USD 388M 62M Sep/2025
Revvity USD 145.83M 47.49M Dec/2025
Tectonic Therapeutic USD -21.52M 374K Dec/2025
Viatris USD -157.5M 392M Dec/2025
Xeris Pharmaceuticals USD 16.77M 10.04M Dec/2025